Bioprogress Future2

STOP F*CKING AROUND PEOPLE. TODAY'S RNS IS FULLY OF JUICY INFORMATION. LET'S DISCUSS THAT.

For example, the deal to buy Dexo included E4.5m which represented 5,866,791 shares as per the RNS.

At today's exchange rate, E4.5m = £3,056,100

SO £3,056,100/5,866,791 shares = 52p per share. What was essentially market value at the time of the RNS. Good for shareholders.

We got much better value for money there than we did with the Fundraising which was at 47p. We should have done an all-stock purchase for Dexo and kept our E8m which was in the back.

Inghu